Last $4.42 USD
Change Today -0.06 / -1.34%
Volume 4.8M
NVAX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John O. Marsh Jr., J.D.

Director Emeritus, Novavax, Inc.
AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 2 different industries.

See Board Relationships
87$79,162

Background*

Mr. John O. Marsh, Jr. serves as a Senior Fellow at the National Center for Technology and Law. Mr. Marsh is a Visiting Professor, George Mason University since 2000; Visiting Professor, Virginia Military Institute during 1998; Interim Chief Executive Officer and Chairman of the Board of Directors of Novavax, Inc. from 1996 to 1997; Secretary of the Army from 1981 to 1989; Counselor with Cabinet rank to the President of the United States from 1974 to 1977; Assistant ...

Read Full Background

Corporate Headquarters*

20 Firstfield Road
Gaithersburg, Maryland 20878

United States

Phone: 240-268-2000
Fax: --

Board Members Memberships*

1991-2014
Director Emeritus

Education*

Unknown/Other Education
Washington University, St. Louis
LLB
Lee University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$43,000
Total Calculated Compensation$79,162
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $4.42 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$557.7K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.